CAS: 32829-58-6; Gigantin

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:WO-2017053290-A1
      优先权日:2015-09-23
      标题:Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
      发明人:GEHLSEN KURT R; JONES TIMOTHY DAVID; CARR FRANCIS JOSEPH; HEARN ARRON
      权利人:RES CORP TECH INC
      摘要:The present application relates to modified T cell epitopes derived from fungal ribotoxins, including α-sarcin, clavin, gigantin, mitogillin, and restrictocin, as well as modified ribotoxin molecules comprising the modified epitopes. The modified ribotoxin molecules inhibit protein synthesis, like the wild type ribotoxins, but exhibit reduced immunogenicity as compared to the corresponding wild type ribotoxin. Another aspect relates to a fusion protein which comprises a modified ribotoxin fused or conjugated or otherwise linked to a targeting molecule that is effective for binding a target of interest. Another aspect relates to the use of the modified ribotoxin or fusion protein for treating or managing a disease or condition.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1055/s-0040-1719850
      摘要:Kiss L, Nonn M, Ouchakour L, Remete AM. Application of Oxidative Ring Opening/Ring Closing by Reductive Amination Protocol for the Stereocontrolled Synthesis of Functionalized Azaheterocycles. Synlett. 2021 Nov 03;33(04):307–28. doi: 10.1055/s-0040-1719850.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知